platinum-based chemotherapy

You have access
Efficacy of Platinum-based Chemotherapy for Platinum-sensitive Recurrent Ovarian Cancer During PARP Inhibitor Treatment: A Multicenter Retrospective Study
ERIKO TAKATORI, TADAHIRO SHOJI, AMI JO, MIKU MUSASHI, SHUNSUKE TATSUKI, NANAKO JONAI, YOHEI CHIBA, SHO SATO, YOSHITAKA KAIDO, TAKAYUKI NAGASAWA, MASAHIRO KAGABU, FUMIAKI TAKAHASHI, TAKESHI AIDA and TSUKASA BABA

Anticancer Research December 2025, 45 (12) 5773-5783; DOI: https://doi.org/10.21873/anticanres.17910
You have access
Organ-specific Tumor Response to Avelumab Maintenance Therapy for Advanced Urothelial Carcinoma: A Multicenter Retrospective Study
NOBUKI FURUBAYASHI, AKINORI MINATO, TOSHIHISA TOMODA, YOSHIFUMI HORI, KEIJIRO KIYOSHIMA, TAKAHITO NEGISHI, YUSUKE HARAGUCHI, TOSHIKI KOGA, KENTARO KUROIWA, NAOHIRO FUJIMOTO and MOTONOBU NAKAMURA

Anticancer Research December 2023, 43 (12) 5689-5698; DOI: https://doi.org/10.21873/anticanres.16774
You have access
Effect of Mirtazapine for the Prevention of Nausea and Vomiting in Patients With Thoracic Cancer Receiving Platinum-based Chemotherapy
MOTOHIKO KINOMURA, HIROTOSHI IIHARA, HIRONORI FUJII, CHIEMI HIROSE, JUNKI ENDO, KOMEI YANASE, TOSHIYA INUI, DAIZO KAITO, YUKA SASAKI, TAKENOBU GOMYO, CHIZURU SAKAI-MASUDA, DAISUKE KAWAE, YU KITAMURA, MASACHIKA FUKUI, RYO KOBAYASHI, YASUSHI OHNO and AKIO SUZUKI

Anticancer Research March 2023, 43 (3) 1301-1307; DOI: https://doi.org/10.21873/anticanres.16277
Open Access
Lung Cancer – Standard Therapy and the Use of a Novel, Highly Effective, Well Tolerated, Treatment With Progesterone Receptor Modulators
JEROME H. CHECK, TRINA PORETTA, DIANE CHECK and MAYA SRIVASTAVA

Anticancer Research March 2023, 43 (3) 951-965; DOI: https://doi.org/10.21873/anticanres.16240
You have access
Survival Prediction by Baseline Systemic Immune-inflammation Index (SII) and its Changes During First-line Platinum-based Treatment in a Caucasian Population of Patients With Metastatic Urothelial Carcinoma (MUC)
PATRIK PALACKA, JAN SLOPOVSKY, JANA OBERTOVA, MICHAL CHOVANEC, KATARINA REJLEKOVA, ZUZANA SYCOVA-MILA, BORIS KOLLARIK, JOZEF MARDIAK and MICHAL MEGO

Anticancer Research November 2021, 41 (11) 5749-5759; DOI: https://doi.org/10.21873/anticanres.15391
You have access
Response to Platinum-based Chemotherapy Rechallenge for Patients With Pembrolizumab-refractory Urothelial Carcinoma
TETSUYA YUMIOKA, MASASHI HONDA, RYUTARO SHIMIZU, SHOGO TERAOKA, NORIYA YAMAGUCHI, BUNYA KAWAMOTO, HIDETO IWAMOTO, SHUICHI MORIZANE, KATSUYA HIKITA and ATSUSHI TAKENAKA

Anticancer Research November 2021, 41 (11) 5767-5773; DOI: https://doi.org/10.21873/anticanres.15393
You have access
Calcitriol Combined With Platinum-based Chemotherapy Suppresses Growth and Expression of Vascular Endothelial Growth Factor of SKOV-3 Ovarian Cancer Cells
JU-HYUN KIM, WOOK HA PARK, DONG HOON SUH, KIDONG KIM, JAE HONG NO and YONG BEOM KIM

Anticancer Research June 2021, 41 (6) 2945-2952; DOI: https://doi.org/10.21873/anticanres.15076
You have access
Clinical Features of Treatment-related Neuroendocrine Prostate Cancer: A Case Series
KOTARO SUZUKI, TOMOAKI TERAKAWA, NAOE JIMBO, RENA INABA, YUZO NAKANO and MASATO FUJISAWA

Anticancer Research June 2020, 40 (6) 3519-3526; DOI: https://doi.org/10.21873/anticanres.14340
You have access
Impact of Maintenance Therapy for Patients with Non-small Cell Lung Cancer in a Real-world Setting
KIYOTAKA YOH, YASUSHI GOTO, YOICHI NAITO, KAZUMA KISHI, KIYOSHI MORI, KATSUYUKI HOTTA, YUKIO HOSOMI, KAZUHIKO YAMADA, CHIHARU TANAI, YOSHIO TOMIZAWA, AKIRA INOUE, YOSHINORI HASEGAWA, MAKOTO NISHIO, YASUO OHASHI and HIDEO KUNITOH

Anticancer Research March 2017, 37 (3) 1507-1513;
You have access
Platinum–Vinorelbine Induction Chemotherapy plus Bevacizumab With and Without Pemetrexed Switch Maintenance in Advanced NSCLC
LINDA MICHELSEN and JENS BENN SØRENSEN

Anticancer Research November 2015, 35 (11) 6255-6259;

Main menu

User menu

Search

platinum-based chemotherapy

Pages